Amanda McQuade and Nathaniel Robichaud discuss how integrated proteomic and transcriptomic profiling can reveal cellular responses to genetic perturbations that are not captured through RNA analysis ...

Large-scale protein and gene profiling have massively expanded the landscape of cancer-associated proteins and gene mutations, but it has been difficult to discern whether they play an active role in ...

Chemical-genetic interaction profiling harnesses the genetic tractability of fungal models to map systematically how small molecules perturb cellular networks. By exposing collections of gene deletion ...

Gene expression profiling using bulk and single-cell transcriptomic techniques has transformed our understanding of osteoarthritis (OA) by depicting the dynamic molecular changes in cartilage, ...

Short interval circulating tumor DNA (ctDNA) kinetics as a predictor of tumor response in patients with gastrointestinal (GI) cancer receiving immune checkpoint inhibitor (ICI)-based treatment. This ...

Colorectal tumors can vary in molecular mutations among individuals and communities, according to a new study from Cedars-Sinai Cancer. Investigators reporting in the journal Cancer Research concluded ...

The impact of glucagon-like peptide-1 agonists on MGUS progression in patients with type 2 diabetes. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, announced today the launch of AML Express, a next-generation sequencing (NGS) assay ...

In a major step towards early detection, University of South Australia researchers are investigating the biology behind multiple sclerosis (MS) to help predict people's genetic risk of developing the ...

The future of personalized medicine is rapidly becoming a reality, powered by advances in genetic testing and healthcare. Once limited to research labs, genetic insights are now transforming how ...